Výsledky vyhledávání

Akademický článek

The first experience of immunotherapy application of ipilimumab in combination with chemotherapy of small-cell lung cancer in the Russian population. Analysis of the combined data of two centers, participating in the multicenter randomized phase III study СА 184-156

Autor: A E Kuzminov, V A Gorbunova, E V Poddubskaya, S G Bagrova, M P Baranova, K K Laktionov

Publikováno v: Современная онкология, Vol 20, Iss 3, Pp 5-9 (2018)

Introduction. Patients with advanced small cell lung cancer (SCLC) have an extremely poor prognosis on the background of standard chemotherapy combination of etoposide and platinum-based drugs. In a randomized, double-blind of СА184-156 phase III s

Externí odkaz: https://doaj.org/article/70bacb626d7349df8314bc1704807dc4

Zobrazit plný text záznamu

New stage in evolution of drug treatment of pleural mesothelioma

Autor: T. D. Barbolina, S. G. Bagrova

Publikováno v: Medical alphabet. :27-30

For a long time, cytostatic therapy practically does not increase life expectancy than up to 18 months. The article describes the latest advances in the development of drug treatment of pleural mesothelioma and the results of the CheckMate‑743 tria

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a20523ae99588a1cc0fca562501227b9
https://doi.org/10.33667/2078-5631-2022-26-27-30

Zobrazit plný text záznamu

Treatment tactics of new NET G3 subgroup in first line of therapy

Autor: E. V. Evdokimova, E. V. Artamonova, V. V. Delectorskaya, G. Yu. Chemeris, G. S. Emelyanova, S. G. Bagrova, A. A. Markovich

Publikováno v: Medical alphabet. :20-24

Considering the fact that the group of neuroendocrine carcinomas (NECs) grade 3 is heterogenous, in the year of 2017 a new subgroup of welldifferentiated neuroendocrine tumors grade 3 (NETs G3) was described. NETs G3 are tumors with more favorable pr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b37a31967156754c5434eac6cfb4ea3f
https://doi.org/10.33667/2078-5631-2021-37-20-24

Zobrazit plný text záznamu

Subpopulation composition of tumor-infiltrating lymphocytes in luminal breast cancer and its effect on effectiveness of neoadjuvant chemotherapy

Autor: S. G. Bagrova, A. V. Egorova, V. I. Kuzmina, E. V. Artamonova, Ya. A. Zhulikov, D. A. Denchik, V. A. Haylenko, E. I. Kovalenko, E. K. Shoua, T. N. Zabotina, Z.G. Kadagidze, M. V. Kiselevsky, I. K. Vorotnikov, E. N. Zakharova, M. V. Khoroshilov

Publikováno v: Medical alphabet. :32-37

Tumor-infiltrating lymphocytes (TILs) play a key role in the formation of anti-tumor immunity and, as studies have shown, can be one of the markers of treatment effectiveness and cancer prognosis. The aim was to study the subpopulation composition of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::af92c1e7a2029c921135b7317df2efa2
https://doi.org/10.33667/2078-5631-2020-29-32-37

Zobrazit plný text záznamu

Derivatives of nitrosoureas in treatment of patients with neuroendocrine tumors. Clinical case of successful treatment of patient with disseminated highly differentiated neuroendocrine pancreatic tumor with severe carcinoid syndrome in fourth line of therapy

Autor: S. G. Bagrova, A. A. Kolomeytseva, N. S. Besova, А. A. Markovich, V. A. Gorbunova, E. V. Artamonova, N. V. Lyubimova, G. S. Emelyanova, Е. I. Kovalenko

Publikováno v: Medical alphabet. :38-41

Advanced well differentiated neuroendocrine tumors (NET) have poor sensitivity to chemotherapy. Approaches to the second and subsequent lines of treatment have not been developed to date Aranosa is a derivative of nitrosourea. it is close to streptoz

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::463d2eae8c2f1f94a1ba486bbb175a68
https://doi.org/10.33667/2078-5631-2020-20-38-41

Zobrazit plný text záznamu

Importance of biochemical markers in routine oncological practice (according to materials of clinical recommendations)

Autor: S. G. Bagrova, N. S. Besova, E. I. Kovalenko, E. V. Artamonova, A. A. Markovich, G. S. Emelyanova, N. V. Lyubimova, V. A. Gorbunova

Publikováno v: Medical alphabet. :19-24

Background. The diagnostics of neuroendocrine tumors (NET) is complex due to many factors such as the heterogeneity of the tumors themselves, different localization of the tumor process, and the presence of severe hormonal syndromes. A special place

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b352d386ea1d278de92bbe7c455a2d53
https://doi.org/10.33667/2078-5631-2020-8-19-24

Zobrazit plný text záznamu

Results of the use of ramucirumab in combination with irinotecan and fluoropyrimidines in the second-line chemotherapy for disseminated gastric cancer

Autor: N. S. Besova, T. A. Titova, D. L. Stroyakovsky, E. V. Perminova, S. G. Bagrova, E. S. Obarevich, V. A. Gorbunova, E. V. Artamonova, I. S. Stilidi

Publikováno v: Медицинский совет, Vol 0, Iss 10, Pp 100-109 (2019)

Background: Several studies show that the combination chemotherapy with ramucirumab allows to improve the treatment results of advanced gastric cancer (GC). Irinotecan with fluoropyrimidines is own of the second line chemotherapy options for these pa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cc0c707208d85133117ee22a446a922
https://doi.org/10.21518/2079-701x-2019-10-100-109

Zobrazit plný text záznamu

Results of the use of trastuzumab combined with different chemotherapy regimens in first-line treatment of HER2-positive disseminated gastric cancer

Autor: N. S. Besova, T. A. Titova, S. G. Bagrova, E. S. Obarevich, V. A. Gorbunova, E. V. Artamonova

Publikováno v: Медицинский совет, Vol 0, Iss 10, Pp 120-127 (2019)

Gastric cancer (GC) is one of the most common types of malignant tumour worldwide and is ranked fifth in the cancer incidence pattern and third in the cancer mortality pattern. In the Russian Federation, 39.9% of patients are diagnosed with stage IV

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d68ccd93cc00c079d7185da758722955
https://doi.org/10.21518/2079-701x-2019-10-120-127

Zobrazit plný text záznamu

Autor: E V Poddubskaya, M P Baranova, Konstantin Laktionov, S. G Bagrova, A E Kuzminov, Vera Gorbunova

Publikováno v: Современная онкология, Vol 20, Iss 3, Pp 5-9 (2018)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::680b301efb3248ab3163ef3478636828
https://modernonco.orscience.ru/1815-1434/article/viewFile/29557/pdf

Zobrazit plný text záznamu

ANALYSIS OF PROTEIN EXPRESSION OF PD-L1 IN MALIGNANT PLEURAL MESOTHELIOMA

Autor: V. M Safronova, N. A Kozlov, L. E Rotobelskaya, M. B Bychkov, S. G Bagrova, Tatyana D. Karpenko, L. N Lubchenko, K. K Laktionov

Publikováno v: Russian Journal of Oncology. 23:4-9

Malignant pleural mesothelioma is associated with poor prognosis and resistance to chemotherapy. This gives reason to search for as well new effective methods of treatment as predictive factors. Programmed cell death receptor PD-1 and its ligands PD-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::269e1261eede93ecb9f40aaa08188bac
https://doi.org/10.18821/1028-9984-2018-23-1-4-9

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání